Role of inflammation in the secondary injury following experimental spinal cord trauma

Journal of Neurosurgical Sciences

Volumn 47, Issue 2, 2003, Pages 89-94

  Conti, A ^a   Cardali, S ^a   Genovese, T ^a   Di Paola, R ^a   La Rosa, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Inflammation; Lipid peroxidation; NF kappa B; Secondary injury; Spinal cord injuries

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MYELOPEROXIDASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLIP; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; LIPID PEROXIDATION; MALE; NERVE CELL; NONHUMAN; RAT; RAT STRAIN; SPINAL CORD INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOPLASM; DISEASE MODELS, ANIMAL; INFLAMMATION; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NF-KAPPA B; PEROXIDASE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD COMPRESSION;

EID: 0345095416     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amar PA, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999;44:1027-40.
2. Blight AR. Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 1992;9:S83-91.
3. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1993;6:712-24.
4. Popovic PG, Reinhard J, Flanagan EM, Stokes BT. Elevation of the neurotoxin quinolinic acid occurs after spinal cord trauma. Brain Res 1994;633:348-52.
5. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-κB activation. J Neurosci 1998;18:3251-60.
6. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Ann Rev Immunol 2000;18:621-62.
7. Lawrence T, Gilroy DW, Coville-Nash PR, Willoughby DA. Possible role for NF-κB in the resolution of inflammation. Nat Med 2001;12:1291-7.
8. Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury in the rat. Surg Neurol 1978;10:38-43.
9. De Medinaceli L. an Anatomical landmark for procedures on rat thoracic spinal cord. Exp Neurol 1986;91:404-8.
10. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Annal Biochem 1979;95:351-8.
11. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharm Meth 1985;14:157-67.
12. Benveniste EN. Inflammatory cytokines within the central nervous system: source, function, and mechanism of action. Am J Physiol 1992;263:C1-16.
13. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system. I. Expression and recognition. Trend Neurosci 1995;18:83-8.
14. Merrill JE, Benveniste EN. Cytokines and inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996;19:331-8.
15. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
16. Kalschmidt B, Baeuerle PA, Kalschmidt C. Potential involvement of the transcription factor NF-κB in neurological disorders. Mol Aspects Med 1993;14:171-90.
17. McDonald PP, Bald A, Cassatella MA. Activation of the NF-κB pathway by inflammatory stimuli in human neutrophils. Blood 1997;89:3421-33.
18. Xu J, Fan G, Chen S, Wu Y, Xu XM, Hsu CY. Methylprednisolone inhibition of TNF-α expression and NF-κB activation after spinal cord injury in rats. Brain Res Mol Brain Res 1998;59:135-42.
19. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM et al. Neuronal (type I) nitric oxide synthase regulates nuclear factor κ B activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci U S A 1997;94:2676-80.
20. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
21. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2000;21:249-51.
22. Hamada Y, Ikata T, Katoh S, Tsuchiya K, Niwa M, Tsutsumishita Y et al. Roles of nitric oxide in compression injury of the rat spinal cord. Free Radical Biol Med 1996;20:1-9.
23. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
24. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993;364:626-32.
25. Liu d, Ling X, Wen J, Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 2000;75:2144-54.
26. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
27. Miscusi M. The role of constitutive nitric oxide synthase in pathogenesis of secondary lesion after spinal cord injury. Preliminary results. J Neurosurg Sci 2002;46:55-9.
28. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42b.
29. Cuzzocrea S, Caputi AP, Zingarelli B. Peroxynitrite-mediated DNA strand breakege activates poly (ADP-ribose) synthetase and causes cellular energy depression in carrageenan-induced pleurisy. Immunology 1998;93:96-101.
30. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, De Sarro A, Van de Loo FA et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 2002;18:169-76.
31. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002;135:496-510.
32. Cuzzocrea S, Costantino G, Mazzon E, Calabro G, Dugo L, De Sarro A et al. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med 2000;162:2065-79.
33. Cuzzocrea S, Mazzon E, Calabro G, Dugo L, De Sarro A, van De Loo FA et al. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med 2001;62:1859-66.
34. Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A et al. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan. Shock 2001;16:51-8.
35. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A et al. Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 2002;17:416-22.
36. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-59.
37. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxydation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-7.
38. st hour after contusion injury in the cat. J Neurosurg 1982;57:247-53.